高级搜索
吴宏增, 赵嘉政, 赵祎, 马晓伟, 冯和林. 横纹肌肉瘤组织中JMJD2B和HIF-1α的表达及其对预后的意义[J]. 肿瘤防治研究, 2021, 48(7): 699-703. DOI: 10.3971/j.issn.1000-8578.2021.21.0030
引用本文: 吴宏增, 赵嘉政, 赵祎, 马晓伟, 冯和林. 横纹肌肉瘤组织中JMJD2B和HIF-1α的表达及其对预后的意义[J]. 肿瘤防治研究, 2021, 48(7): 699-703. DOI: 10.3971/j.issn.1000-8578.2021.21.0030
WU Hongzeng, ZHAO Jiazheng, ZHAO Yi, MA Xiaowei, FENG Helin. Expression of JMJD2B and HIF-1α in Rhabdomyosarcoma Tissues and Their Prognostic Significance[J]. Cancer Research on Prevention and Treatment, 2021, 48(7): 699-703. DOI: 10.3971/j.issn.1000-8578.2021.21.0030
Citation: WU Hongzeng, ZHAO Jiazheng, ZHAO Yi, MA Xiaowei, FENG Helin. Expression of JMJD2B and HIF-1α in Rhabdomyosarcoma Tissues and Their Prognostic Significance[J]. Cancer Research on Prevention and Treatment, 2021, 48(7): 699-703. DOI: 10.3971/j.issn.1000-8578.2021.21.0030

横纹肌肉瘤组织中JMJD2B和HIF-1α的表达及其对预后的意义

Expression of JMJD2B and HIF-1α in Rhabdomyosarcoma Tissues and Their Prognostic Significance

  • 摘要:
    目的 探讨组蛋白去甲基化酶JMJD2B和HIF-1α在横纹肌肉瘤(RMS)组织中的表达及意义。
    方法 选取78例RMS患者通过随访获取生存时间,采用免疫组织化学染色法检测JMJD2B和HIF-1α在RMS组织中的表达情况并分析其与患者临床病理特征及预后的关系。
    结果 78例样本中,JMJD2B和HIF-1α表达阳性例数分别为46例(59.0%)和44例(56.4%)。JMJD2B和HIF-1α的表达成正相关(P < 0.001, r=0.518)且与肿瘤的危险度、治疗、转移、分期有关(均P < 0.05)。生存分析显示危险度的级别、新辅助化疗的有无、HIF-1α和JMJD2B表达的高低与患者预后相关(均P < 0.05)。多因素Cox回归分析进一步显示JMJD2B(HR=3.161, P=0.039)和危险度(HR=2.925, P=0.001)可作为RMS患者独立的预后因素。
    结论 JMJD2B和HIF-1α的表达与横纹肌肉瘤的总体生存密切相关,JMJD2B是横纹肌肉瘤患者的独立预后指标。

     

    Abstract:
    Objective To explore the expression and prognostic significance of histone demethylase JMJD2B and HIF-1α in rhabdomyosarcoma(RMS) tissues.
    Methods A total of 78 RMS patients were followed up to obtain survival time, and immunohistochemical staining was used to detect the expression of JMJD2B and HIF-1α in RMS tissues and analyze their relation with clinicopathological characteristics and prognosis.
    Results Among the 78 samples, there were 46 (59.0%) and 44 (56.4%) cases of positive expression of JMJD2B and HIF-1α, respectively. The expression of JMJD2B and HIF-1α were positively correlated (P < 0.001, r=0.518) and related to tumor risk, metastasis, IRS staging and neoadjuvant chemotherapy (all P < 0.05). The Kaplan-Meier survival curve and univariate Cox regression analysis showed that the risk level, neoadjuvant chemotherapy, the expression of HIF-1α and JMJD2B were related to the prognosis of patients (all P < 0.05). Multivariate Cox regression analysis showed that JMJD2B (HR=3.161, P=0.039) and risk degree (HR=2.925, P=0.001) could be used as independent prognostic factors for RMS patients.
    Conclusion JMJD2B and HIF-1α expression are both significantly related to the overall survival of rhabdomyosarcoma patients, and JMJD2B is an independent prognostic indicator.

     

/

返回文章
返回